CSIMarket
 
Verrica Pharmaceuticals Inc.  (VRCA)
Other Ticker:  
 
 


The company published Revenue of $0.214 millions, in the financial interval ending June 30 2022

Verrica Pharmaceuticals Inc. reported second quarter of 2022 operating shortfall of $-9.121 millions

Published 2022-08-13T20:23:48-04:00
Goran Soko / CSIMarket.com Contributer

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Verrica Pharmaceuticals Inc. has seen $0.214 millions, in Revenue in the second quarter of 2022.




In the second quarter of 2022 Verrica Pharmaceuticals Inc. reported net loss of $-10.168 million, instead of deficit of $-11.775 millions in the same reporting period a year ago.


Verrica Pharmaceuticals Inc. is expected to report next financial earnings on November 11, 2022.


    Recently Reported Results
tax-468440__340 Technology And Telecommunication Acquisition Corpo

As one of many businesses, the TETE reported as well its third quarter of 2022 numbers

After the big players in the Blank Checks sector, a few lesser known businesses are reporting the respective results. TETE told it has booked operating deficit of $-0.0525 millions, for the third quarter of 2022.


Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Construction Spending

U.S. construction spending dropped in the June 2022

Outlays for U.S. construction projects fell after recent increases, as decline in private spending offset an increase in public spending.

HK_ICC_Imperial_Cullinan_showflats_By_Keithmenorm_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Verus International Inc.

For the third quarter of 2022 earnings season Verus International Inc. reached 0 of $0.00 per share compare to $-0.02 a year prior and from $-0.01 per share from the previous financial reporting period.

Revenues remained unscathed to $0.00 millions from $1.85 millions in the similar financial reporting period a year prior and sequentially Revenue Tumbled from $0.00 millions.


architecture-2256489_960_720 Selectis Health Inc.

For the most recent fiscal period GBCS bottom-line turned positive of $0.34 per share compare to $-0.03 a year ago and Income per Share grown rapidly by 385.71 % from $0.07 per share from the prior quarter.

Revenues remained unscathed to $-0.00 millions from $6.01 millions in the comparable quarter a year ago and sequentially Revenue Tumbled from $-0.00 millions.


Traders_on_Monday_pd Lvpai Group Limited

For the second quarter of 2022 earnings season FTGI Deficit has expanded of $-0.09 per share compare to $0.00 a year before and EPS improved from $-0.16 per share from the preceding quarter.

Revenues remained unaltered to $-0.00 millions from $0.00 millions in the same quarter a year before and sequentially Revenue Tumbled from $0.00 millions.


Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons Consumer Price Index

Consumer Prices returned to Growth in August 2022

U.S. CPI on the rise again after stagnation in the last month, as a decline in energy costs didn't immediately filter through the rest of the economy.

unemployed_lines_pd Employment Report

Economy gains 528,000 jobs in July 2022, unemployment rate 3.5 %

The nonfarm payrolls grew 528,000 in July 2022, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,

turn-on-2932999__340 Producer Price Index

Wholsale prices continued to decline in August 2022

U.S. Producer prices continued to fell in August 2022, due to constant decline in petroleum prices.

Ear_surgery_on_a_patient_pd Bitech Technologies Corporation

Bitech Technologies Corporation reported that Revenues have more than doubled, in the second quarter of 2022 earnings season

SPIN announced very strong Revenue growth of 162.936 % year on year to $0.08 millions in the second quarter of 2022 earnings season, but Diminishing Returns have widen at $-0.01.


F-16_Fighting_Falcon_Preflight_Checks_pd Madison Technologies Inc.

Madison Technologies Inc. has failed to turn into profitability despite the epic Surge in Revenues the company over the second quarter of 2022 earnings season

Madison Technologies Inc. announced very strong Revenue advance year on year to $0.47 millions in the second quarter of 2022 earnings season, but reached break-even at $-0.00.


drilling_engineering_lathe_manufacturing_machine_metal_industrial_machining-771478 Taylor Devices Inc

earnings have truly advanced the Taylor Devices Inc over the financial fourth quarter of 2022

the Industrial Machinery and Components company has truly advanced its earnings in the financial fourth quarter of 2022 from same quarter a year ago, EPS soared by 1321.84 % to $0.71 and Revenue soared by 164.924 % to $12.64 millions.


Carnival Corporation

A Blowout results, by the company during the third quarter of 2022

For the third quarter of 2022 company decreased loss per share of $-0.65 per share compare to $-2.50 a year prior and EPS improved from $-1.61 per share from the previous reporting season.

Revenues grew sharply by 688.462 % to $4.31 billions from $546.00 millions in the similar reporting season a year prior and sequentially Revenues surged by 79.3 % from $2.40 billions.


urban-438393_960_720 Bed Bath And Beyond Inc

The unpleasant -27.595 % fall in Revenues at the company over the second quarter of 2022

Weak demand caused rise in losses for the fiscal span ending August 27 2022, BBBYs' a shortfall per share inched up to $-4.59 from $-0.72 where Revenue fell by -27.595 % to $1.44 billions from $1.98 billions a year prior.


MTDR-_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Ennis Inc.

Strong Eps Underlines Double Digits Revenues growth at the company during the most recent fiscal period

Considering the most recent fiscal period profitability jumped by 62.07 % to $0.47 per share, followed by Revenue boost of 10.734 % to $111.23 millions, compared with the prior year period.




Other VRCA's Earnings Reports

Verrica Pharmaceuticals reported first quarter 2022 earnings

Verrica Pharmaceuticals reported fourth quarter 2022 earnings

Verrica Pharmaceuticals reported third quarter 2021 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JYAC's Profile

Stock Price

JYAC's Financials

Business Description

Fundamentals

Charts & Quotes

JYAC's News

Suppliers

JYAC's Competitors

Customers & Markets

Economic Indicators

JYAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071